New Alzheimer’s disease drug gets FDA green light

New Alzheimer’s disease drug gets FDA green light

From AARP.org —   By Rachel Nania —  The U.S. Food and Drug Administration (FDA) on Jan. 6 granted accelerated approval to lecanemab (brand name Leqembi), a drug that in initial clinical trials slowed the rate of cognitive decline in patients in the early stages of...
For caregivers, holidays present challenges: Here’s how to help

For caregivers, holidays present challenges: Here’s how to help

From The Plain Dealer —   By GRETCHEN CUDA KROEN —  CLEVELAND, Ohio — The holidays can be a stressful time of year for anyone, but for those who have taken on the role of caregiver for an aging or disabled family member, the holiday season can be especially...
Medicare pay cuts will hurt seniors’ care, doctors argue

Medicare pay cuts will hurt seniors’ care, doctors argue

From the Kaiser Family Foundation —  By Michael McAuliff —  Doctors are urging Congress to call off cuts scheduled to take effect on Jan. 1 in the reimbursements they receive from Medicare. In what has become an almost yearly ritual, physician groups are arguing that...